NCRI Lymphoma and Radiotherapy Group: FoRT

A PHASE III MULTI-CENTRE RANDOMISED CONTROLLED TRIAL OF LOW DOSE PALLIATIVE RADIOTHERAPY FOR FOLLICULAR LYMPHOMA

This is a phase III multi-centre open randomised study comparing low dose palliative radiotherapy (4Gy) with a control group receiving 24Gy for follicular lymphoma. Patients will be randomised to receive either 4Gy in 2 fractions (experimental arm) over the course of 2 consecutive days or 24Gy in 12 fractions (control) over 16 days treating daily Monday to Friday. Involved field radiotherapy will be given based on the tumour mass rather than anatomical regions. This is a UK multi-centre study co-ordinated under the auspices of Cancer Research UK and the NCRI Radiotherapy and Lymphoma Clinical Studies Group.

Chief Investigator:

Prof Peter J Hoskin

Marie Curie Research Wing

Mount Vernon Hospital

Rickmansworth Road

Northwood

Middlesex HA6 2RN

UK

Quality Assurance Physicist:

Patty Díez

Clinical Physics

Mount Vernon Hospital

Rickmansworth Road

Northwood

Middlesex HA6 2RN

UK

Tel: 01923-844229

Bleep: 01923-826111 blp 151

patricia.diez@ nhs.net

Trials Office:

Bilyana Popova

Haematology Trials Group

Cancer Research UK & UCL Cancer Trials Centre

222 Euston Road

London NW1 2DA

UK

b.popova@ctc.ucl.ac.uk

Please direct any QA queries or comments to Patty, otherwise email trials@rttrialsqa.org.uk

Other lymphoma clinical trials involving radiotherapy:

v 18-30: modified German Paediatric Hodgkin’s Lymphoma protocol (HD95) in young adults (aged 18-30 years) with Hodgkin’s Lymphoma

v RAPID: role of FDG-PET in Hodgkin’s lymphoma

v Stanford V vs. ABVD for Advanced Hodgkin’s Disease

QUALITY ASSURANCE PROGRAMME

Questionnaire You should also complete the baseline and staff questionnaires on the RTTQA homepage	TLDs SIM-PLANNED CT-PLANNED ELECTRONS
Annual RT Meetings For information about presentations and workshops please contact Patty Díez